55 Claverick St., Room 325
Providence, Rhode Island 02903
June 21, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joe McCann and Arzhang Navai
| Re: | Ocean Biomedical, Inc. Registration Statement on Form S-1 File No. 333-271392 |
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effectiveness of the above-captioned Registration Statement on Form S-1 be accelerated so that the same will become effective at 4:30 p.m. Eastern Time on June 22, 2023, or as soon thereafter as practicable.
| Very truly yours, | ||
| OCEAN BIOMEDICAL, INC. | ||
| By: | /s/ Elizabeth Ng | |
| Name: | Elizabeth Ng | |
| Title: | Chief Executive Officer | |
| cc: | Kate Bechen, Esq. |
| Thomas S. Vaughn, Esq. | |
| Joseph R. DeHondt, Esq. |